Skip to main content
Livermore
Livermore
ZHEN

Journey Medical Corp

DERM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001867066

No open-market purchases or sales by Journey Medical Corp insiders were filed in the last 90 days; 71 institutions reported holding it in 13F filings for Q2 2026, worth $75.2M in total; no superinvestor holds it.

Holders of 5% or more of DERM

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Journey Medical Corp, largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of DERM
HolderLatest formStakeChangeFirst filedLatest filingFiling
Tang Capital Management LLC13G/A8.00%1.85M shares–May 15, 20251 filingMay 15, 2025SEC
Wasatch Advisors Inc13G/A6.70%1.15M shares+1.30 ppfrom 5.40%May 13, 20252 filingsAug 14, 2025SEC
Vanguard Capital Management LLC13G5.65%1.21M sharesNewApr 30, 20261 filingApr 30, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

4 Schedule 13D and 13G filings on Journey Medical Corp, newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on DERM
Filed (ET)FilerFormStakeChangeEvent dateFiling
Apr 30, 202611:03 AM ETVanguard Capital Management LLC13G5.65%1.21M sharesNewMar 31, 2026SEC
Aug 14, 20251:21 PM ETWasatch Advisors Inc13G/A6.70%1.15M shares+1.30 ppfrom 5.40%Jun 30, 2025SEC
May 15, 20254:15 PM ETTang Capital Management LLCand 5 others13G/A8.00%1.85M shares–Mar 31, 2025SEC
May 13, 20254:10 PM ETWasatch Advisors Inc13G5.40%930.6K sharesNewMar 31, 2025SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Journey Medical Corp shares.

No Form 144 notices for Journey Medical Corp are on file.